Catalyst Wire Dossier Catalyst Wire Dossier

Pedea

ibuprofen · Recordati Rare Diseases
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pedea, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: EMA Authorised: Pedea (Ibuprofen) — Recordati Rare Diseases

See pricing